ConductScience.org, home

Paper20180652

Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.

Boyer JL and 7 others. Hum Gene Ther, 2010. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid. Papers, record 20180652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20180652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.
PubMed
Journal
Hum Gene Ther
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.77
iCite
Revised in PubMed
2021-10-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boyer JLJulie L
2Sofer-Podesta CCarolina
3Ang JJohn
4Hackett NRNeil R
5Chiuchiolo MJMaria J
6Senina SSvetlana
7Perlin DDavid
8Crystal RGRonald G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenoviridaeMajor topic
Antigens, BacterialMajor topic
Bacterial ProteinsMajor topic
Bacterial VaccinesMajor topic
CapsidMajor topic
PlagueMajor topic
Pore Forming Cytotoxic ProteinsMajor topic
Yersinia pestisMajor topic
Blotting, Western
Genetic Vectors
Immunization
Recombinant Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U54 AI057158NIAID NIH HHSUnited StatesU54AI057158PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117966437Protective immunity against plague.Adv Exp Med Biol2007https://conductscience.org/library/papers/17966437PubMed
217287055A plant-produced plague vaccine candidate confers protection to monkeys.Vaccine2007https://conductscience.org/library/papers/17287055PubMed
316243411Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.Vaccine2006https://conductscience.org/library/papers/16243411PubMed
417376861Development of in vitro correlate assays of immunity to infection with Yersinia pestis.Clin Vaccine Immunol2007https://conductscience.org/library/papers/17376861PubMed
59660466Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice.Am J Trop Med Hyg1998https://conductscience.org/library/papers/9660466PubMed
619124600Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge.Infect Immun2009https://conductscience.org/library/papers/19124600PubMed
79334364Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.J Exp Med1997https://conductscience.org/library/papers/9334364PubMed
811779413Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions.Hum Gene Ther2002https://conductscience.org/library/papers/11779413PubMed
98892868Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.J Virol1996https://conductscience.org/library/papers/8892868PubMed
1015996701Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.Virology2005https://conductscience.org/library/papers/15996701PubMed
111370653In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.Cell1992https://conductscience.org/library/papers/1370653PubMed
1211356075Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.Mol Ther2001https://conductscience.org/library/papers/11356075PubMed
1313808585The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague.J Immunol1959https://conductscience.org/library/papers/13808585PubMed
1419200825A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.Vaccine2009https://conductscience.org/library/papers/19200825PubMed
1511863421Effect of adenovirus gene transfer vectors on the immunologic functions of mouse dendritic cells.Mol Ther2002https://conductscience.org/library/papers/11863421PubMed
1617416264Plague.Lancet2007https://conductscience.org/library/papers/17416264PubMed
1711779412Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions.Hum Gene Ther2002https://conductscience.org/library/papers/11779412PubMed
1818324890Current challenges in the development of vaccines for pneumonic plague.Expert Rev Vaccines2008https://conductscience.org/library/papers/18324890PubMed
1912072490Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.J Virol2002https://conductscience.org/library/papers/12072490PubMed
2015841217Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.J Clin Invest2005https://conductscience.org/library/papers/15841217PubMed

See all 61 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42576894Anti-infective compounds for Yersinia.Sustain Microbiol2026https://conductscience.org/library/papers/42576894PubMed
39242587Progress on the research and development of plague vaccines with a call to action.NPJ Vaccines2024https://conductscience.org/library/papers/39242587PubMed
33514747A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform.NPJ Vaccines2021https://conductscience.org/library/papers/33514747PubMed
30049954Progress in Adenoviral Capsid-Display Vaccines.Biomedicines2018https://conductscience.org/library/papers/30049954PubMed
29725025Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.Sci Rep2018https://conductscience.org/library/papers/29725025PubMed
28362809Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.PLoS One2017https://conductscience.org/library/papers/28362809PubMed
28207901YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.PLoS One2017https://conductscience.org/library/papers/28207901PubMed
28018363Plague Vaccine Development: Current Research and Future Trends.Front Immunol2016https://conductscience.org/library/papers/28018363PubMed
27722869Plague Vaccines: Status and Future.Adv Exp Med Biol2016https://conductscience.org/library/papers/27722869PubMed
25703559B cells and antibodies in the defense against Mycobacterium tuberculosis infection.Immunol Rev2015https://conductscience.org/library/papers/25703559PubMed
24981329The effect of fiber truncations on the stability of adenovirus type 5.Mol Biotechnol2014https://conductscience.org/library/papers/24981329PubMed
24444179Adenovirus: the first effective in vivo gene delivery vector.Hum Gene Ther2014https://conductscience.org/library/papers/24444179PubMed
23707160Prospects for oral replicating adenovirus-vectored vaccines.Vaccine2013https://conductscience.org/library/papers/23707160PubMed
22089246Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity.Clin Vaccine Immunol2012https://conductscience.org/library/papers/22089246PubMed
21918302Developing live vaccines against plague.J Infect Dev Ctries2011https://conductscience.org/library/papers/21918302PubMed
21130482Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors.Virology2011https://conductscience.org/library/papers/21130482PubMed
21047139Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.Mol Pharm2011https://conductscience.org/library/papers/21047139PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20180652

GET https://conductscience.org/api/papers/v1/20180652/references?page=2